Small RNAs might drive COPD progression: Research lays foundation for potential new diagnostics and therapies

Small RNAs might drive COPD progression: Research lays foundation for potential new diagnostics and therapies

Chronic obstructive pulmonary disease (COPD) affects nearly 12 million people in the U.S. alone and is the third leading cause of death worldwide. High levels of immune molecules known as cytokines, which can damage the lungs, are a hallmark of COPD.

​Medical Xpress – latest medical and health news stories

Read More

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *